Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulation

Thrombosis Research

Volumn 117, Issue 4, 2006, Pages 419-427

  Kim, Sang Kyoon ^a   Vaishali, Bagalkot ^a   Lee, Eunhye ^a   Lee, Seulki ^a   Lee, Yong Kyu ^a   Kumar, Tadiparthi Suresh ^a   Moon, Hyun Tae ^b   Byun, Youngro ^a,b  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

^b Mediplex Corporation   (South Korea)

Author keywords

Conjugate; Deoxycholic acid; DMSO; Low molecular weight heparin; Oral delivery

Indexed keywords

ANTICOAGULANT AGENT; DEOXYCHOLIC ACID; DIMETHYL SULFOXIDE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ANIMAL EXPERIMENT; ANTICOAGULATION; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SYNTHESIS; HISTOLOGY; LUNG EMBOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTICOAGULANTS; CHOLAGOGUES AND CHOLERETICS; DEOXYCHOLIC ACID; DRUG CARRIERS; DRUG COMBINATIONS; DRUG COMPOUNDING; DRUG EVALUATION, PRECLINICAL; HEPARIN; INTESTINES; MALE; MICE; MICE, INBRED ICR; WATER;

EID: 32044444307     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.03.027     Document Type: Article

References (27)

1. A.S. Gallus Anticoagulants in the prevention of venous thromboembolism Baillieres Clin Haematol 3 1990 651 684
2. J.B. Hardman, and L.E. Limbird Anticoagulants, thrombolytic, chromatogand antiplatelet drugs Goodman and Gilman's the pharmacological basis of therapeutics 1996 Macmillan New York 1344 1346
3. H. Jack, S.A. Sonia, L.H. Jonathan, and F. Valentin Guide to anticoagulant therapy: heparin Circulation 103 2001 2994 3018
4. S.R. Money, and J.W. York Development of oral heparin therapy for prophylaxis and treatment of deep venous thrombosis Cardiovasc Surg 9 2001 211 218
5. E. Grau, J.M. Tenias, and E. Real Home treatment of deep venous thrombosis with low molecular weight heparin: long-term incidence of recurrent venous thromboembolism Am J Hematol 67 2001 10 14
6. H.K. Breddin, V. Hach-Wunderle, and R. Nakov Effect of a low molecular weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis N Engl J Med 344 2001 626 631
7. L.M. Hiebert, T. Ping, and S.M. Wice Antithrombotic activity of orally administered low molecular weight heparin (Logiparin) in a rat model Haemostasis 30 2000 196 203
8. C. Pinel, S.M. Wice, and L.M. Hiebert Orally administered heparins prevent arterial thrombosis in a rat model Thromb Haemost 91 2004 919 926
9. I.A. Greer Prevention of venous thromboembolism in pregnancy Best Pract Res Clin Haematol 16 2003 261 278
10. J.M. Dunn, and A.S. Hollister Oral bioavailability of heparin using a novel delivery system Curr Ther Res 56 1995 738 745
11. P. Couvreur, D. Duchéne, and I. Kalles Formulation of poorly-available drugs for oral administration Symposium 1996 Editions de Sante Paris
12. Gattefossé SA. Microemulsions. Formulation Guide (patented technology). 1998.
13. A. Dal Pozzo, M. Acquasaliente, and M.R. Geron New heparin complexes active by intestinal absorption: I. Multiple ion pairs with basic organic compounds Thromb Res 56 1989 119 124
14. D. Malkov, W. Huai-zhen, S. Dinh, and I. Gomez-Orellana Pathway of oral absorption of heparin with sodium N-[8-(2 hydroxybenzoyl)amino]caprylate Pharm Res 19 2002 1180 1184
15. D.G. Mark, D.M. Jeffrey, and L.B. Andrea Orally administered heparin for preventing deep venous thrombosis Am J Surg 176 1998 176 178
16. Y.K. Lee, H.T. Moon, and Y.R. Byun Preparation of slightly hydrophobic heparin derivatives which can be used for solvent casting in polymeric formulation Thromb Res 92 1998 149 156
17. Y.K. Lee, S.H. Kim, and YR. Byun Oral delivery of new heparin derivatives in rats Pharm Res 17 2000 1259 1264
18. Y.K. Lee, J.H. Nam, H.C. Shin, and Y.R. Byun Conjugation of low-molecular-weight heparin and deoxycholic acid for the development of a new oral anticoagulant agent Circulation 104 2001 3116 3120
19. P. Popesko, V. Rajtova, and J. Horak A colour atlas of the anatomy of small laboratory animals vol. 2 1992 Wolfe Publishing Bratislava 11 104
20. M. Schwarz, D.W. Russell, J.M. Dietschy, and S.D. Turley Marked reduction in bile acid synthesis in cholesterol 7α-hydroxylase deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolaemia J Lipid Res 39 1998 1833 1843
21. M. Fuchs, F. Lammert, D.O. Wang, B. Paigen, M.C. Carey, and D.E. Cohen Sterol carrier protein 2 participates in hypersecretion of biliary cholesterol during gallstone formation in genetically gallstone-susceptible mice Biochem J 336 1998 33 37
22. J.L. Porter, J.S. Fordtran, C.A. Santa Ana, M. Emmett, L.R. Hagey, and L.R. Macdonald Accurate enzymatic measurement of fecal bile acids in patients with malabsorption J Lab Clin Med 141 2003 411 418
23. M.Y. Qureshi, S.M. Smith, and G.M. Murphy Colorimetric enzymatic measurement of serum total 3α-hydroxy bile acid concentrations without extraction J Clin Pathol 37 1986 317 320
24. E.C. Lavelle, and J.E. Harris The processing of an orally administered protein antigen in the digestive tract of rainbow trout, oncorhynchus my kiss Comp Biochem Physiol 117 1997 263 275
25. L.M. Hiebert, S.M. Wice, and T. Ping Tissue distribution of the low molecular weight heparin, tinzaparin, following administration to rats by the oral route Biomed Pharmacother 58 2004 372 438
26. Web site: http://www.gaylordchemical.com/bulletins/MSDGC1-5.pdf.
27. D. Aguilar, and S. Goldhaber Clinical uses of low molecular weight heparins Chest 115 1999 1418 1423